Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Evaluation of Efficacy and Safety of Front-Line Regimens for the Treatment of Transplant Ineligible Patients with Multiple Myeloma: A Network Meta-Analysis of Phase 2/3 Randomized Controlled Trials

Smith Giri, MBBS, Madan R Aryal, MD, Han Yu, PhD, Alyssa Grimshaw, MSLIS, Ranjan Pathak, MD, Scott F. Huntington, MD MPH, Binod Dhakal, MBBS

Blood (2019) 134 (Supplement_1): 2188.

https://doi.org/10.1182/blood-2019-130389

Published: 2019

Journal Articles

A Network Meta-Analysis (NMA) to Evaluate Comparative Effectiveness of Frontline Treatments for Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Who Are Transplant-Ineligible (TIE)

Thierry Facon, MD, Jesús San-Miguel, Saad Z. Usmani, MD, Meletios A. Dimopoulos, MD, Shaji K. Kumar, MD, Maria-Victoria Mateos, Michele Cavo, Bart Heeg, PhD, Sophie Van Beekhuizen, MSc, Marta Pisini, MBA, Sandhya Nair, Annette Lam, BSc, MSc, Mary Slavcev, Jianming He, PhD

Blood (2019) 134 (Supplement_1): 2144.

https://doi.org/10.1182/blood-2019-123561

Published: 2019

Journal Articles

A Network Meta-Analysis of Clinical Trials Assessing Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Among Young Adults

Nour Tlimat, MD, Salman Muddassir, Saad Ullah Malik, Warda Faridi, MD, Qurat Ul Ain Riaz Sipra, MBBS, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 1432.

https://doi.org/10.1182/blood-2018-99-119646

Published: 2018

Journal Articles

Aspirin Use in Venous Thromboembolism Prophylaxis Following Hip or Knee Arthroplasty: A Network Meta-Analysis of Randomized Controlled Trials

Tarek Haykal, MD, Babikir Kheiri, MD, Mahmoud Barbarawi, MD, Yazan Zayed, MD, Muhammad Shah Miran, MD, Adam Chahine, MD, Ahmed Abdalla, MD, Khalil Katato, MD, Ghassan Bachuwa, MD MHSA, MS, Tarik Hadid, MD MS, Zyad Kafri, MDMS

Blood (2018) 132 (Supplement 1): 1240.

https://doi.org/10.1182/blood-2018-99-118635

Published: 2018

Journal Articles

Treatment Regimens for Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Stem Cell Transplantation: A Systematic Literature Review and Network Meta-Analysis

Jesus F San-Miguel, MD PhD, Thierry Facon, Meletios A Dimopoulos, MD, Maria-Victoria Mateos, MD PhD, Michele Cavo, MD, Bart Heeg, PhD, Sophie van Beekhuizen, Marta Pisini, MBA, Sandhya Nair, Annette Lam, Mary Slavcev

Blood (2018) 132 (Supplement 1): 4741.

https://doi.org/10.1182/blood-2018-99-113668

Published: 2018

Journal Articles

Relative Efficacy of Treatment Options in Newly Diagnosed Multiple Myeloma: Results from a Systematic Literature Review and Network Meta-Analysis

Karthik Ramasamy, Howard Thom, Vijay K. D'Souza, Vanessa Buchanan, Sujith Dhanasiri

Blood (2018) 132 (Supplement 1): 4744.

https://doi.org/10.1182/blood-2018-99-112882

Published: 2018

Journal Articles

Estimating the Effect of Individual Agents in the Treatment of Relapsed, Refractory Multiple Myeloma (RRMM)

Neil Hawkins, Karthik Ramasamy, Sujith Dhanasiri

Blood (2018) 132 (Supplement 1): 2013.

https://doi.org/10.1182/blood-2018-99-111804

Published: 2018

Journal Articles

Comparison of Different Rabbit Anti-Thymocyte Globulin Formulations in Allogeneic Stem Cell Transplantation: Systematic Literature Review and Network Meta-Analysis

Nico Gagelmann, Francis A Ayuk, Christine Wolschke, Nicolaus Kroeger, MD

Blood (2017) 130 (Supplement 1): 1969.

https://doi.org/10.1182/blood.V130.Suppl_1.1969.1969

Published: 2017

Journal Articles

Direct Oral Anticoagulants for the Prevention of Recurrent Venous Thromboembolism: A Systematic Review & Network Meta-Analysis

Mia Djulbegovic, MD, Alfred Lee, MD PhD

Blood (2017) 130 (Supplement 1): 4721.

https://doi.org/10.1182/blood.V130.Suppl_1.4721.4721

Published: 2017

Journal Articles

A Systematic Review and Network Meta-Analysis of Maintenance Treatment for Patients with Newly Diagnosed Multiple Myeloma Post-Autologous Stem Cell Transplant

Susanne Schmitz, Vanessa Buchanan, Joy Leahy, Sujith Dhanasiri, MSc, Charlotte Pawlyn, BA,PhDMBBChir,MRCP,FRCPath, John Ashcroft

Blood (2017) 130 (Supplement 1): 1832.

https://doi.org/10.1182/blood.V130.Suppl_1.1832.1832

Published: 2017

Journal Articles

Risk of Intracranial Hemorrhage with Direct Oral Anticoagulants: A Traditional and Network Meta-Analysis

Zachary Wolfe, MD, Fahad Nasir, MD, Charumathi Subramanian, MD, Safi Khan, MD, Bradley W. Lash, MD

Blood (2017) 130 (Supplement 1): 2387.

https://doi.org/10.1182/blood.V130.Suppl_1.2387.2387

Published: 2017

Journal Articles

Systematic Literature Review and Network Meta-Analysis of Treatments for Relapsed/Refractory Multiple Myeloma Patients

Chrissy H. Y. Van Beurden-Tan, MSc, Margreet Franken, PhD, Hedwig Blommestein, PhD, Carin A. Uyl-De Groot, PhD, Pieter Sonneveld, MD PhD

Blood (2016) 128 (22): 2144.

https://doi.org/10.1182/blood.V128.22.2144.2144

Published: 2016

Journal Articles

Impact of Dose-Difference in Comparator Arms Among Clinical Trials on Treatment Effect Size in a Network Meta-Analysis: A Case of First-Line Therapies in Chronic Lymphocytic Leukemia (CLL)

Mkaya Mwamburi, PhD MD MA, Vasudha Bal, MSc, MBA, Teresa Cascella, MD, Anshul Shah, B.Pharm, MS, Merena Nanavaty, B. Pharm, MS, Smeet Gala, B.Tech, MS

Blood (2016) 128 (22): 5593.

https://doi.org/10.1182/blood.V128.22.5593.5593

Published: 2016

Journal Articles

Efficacy of First-Line CLL Treatments in Comparison to Chlorambucil: A Network Meta-Analysis

Belal Firwana, MD, Mohamad Bassam Sonbol, MD, Shebli Atrash, MD, Rahul Ravilla, MD, Mihir Raval, MD MPH, Lin Hao, MD, Yogesh Jethava, MB, MRCP, MD FRCPath, Muthu Veeraputhiran, MD MPH, Issam Makhoul, MD, Appalanaidu Sasapu, MD MS

Blood (2016) 128 (22): 5594.

https://doi.org/10.1182/blood.V128.22.5594.5594

Published: 2016

Journal Articles

Estimating the Relative Effectiveness of Treatments in Relapsed/Refractory Multiple Myeloma through a Systematic Review and Network Meta-Analysis

Kai Ruggeri, PhD, Áine Maguire, MSc, Susanne Schmitz, PhD, Elisa Haller, MSc, Cathal Walsh, PhD, Jack Bowden, PhD, Isla Kuhn, Ayesha Khan, PhD, Gordon Cook, MD PhD, Michael O'Dwyer, MD

Blood (2015) 126 (23): 2103.

https://doi.org/10.1182/blood.V126.23.2103.2103

Published: 2015

Journal Articles

Comparative Analysis of Azacitidine and Decitabine in Myelodysplastic Syndromes: A Systematic Review and Network Meta-Analysis

Jehad Almasri, MD, Hassan B Alkhateeb, MD, Moussab Damlaj, MD, Zhen Wang, PhD, M. Hassan Murad, MD, Aref Al-Kali, MD

Blood (2015) 126 (23): 1692.

https://doi.org/10.1182/blood.V126.23.1692.1692

Published: 2015

Journal Articles

Bayesian Network Meta-Analysis (NMA): Safety of Bortezomib, Thalidomide or Lenalidomide Containing Regimens for Transplant Ineligible Multiple Myeloma (MM) Patients

Toshihisa Satta, Norihiro Yamaguchi, Adriana Malone, MD, James Talcott, Ajai Chari, MD

Blood (2015) 126 (23): 3030.

https://doi.org/10.1182/blood.V126.23.3030.3030

Published: 2015

Journal Articles

Efficacy Of Novel Agents As Maintenance Therapy For Multiple Myeloma: A Direct and Network Meta-Analysis

Tea Reljic, BS, Ambuj Kumar, MD, MPH, Helen Mahoney, MPH, Branko Miladinovic, PhD, Mohamed A Kharfan-Dabaja, MD, Rahul Mhaskar, MPH, PhD, Benjamin Djulbegovic, MD, PhD

Blood (2013) 122 (21): 1945.

https://doi.org/10.1182/blood.V122.21.1945.1945

Published: 2013

Journal Articles

Maintenance Therapies for Multiple Myeloma (MM): A Network Meta-Analysis

Helen Mahony, MPH, Ambuj Kumar, MD, MPH, Rahul Mhaskar, MPH, PhD, Branko Miladinovic, PhD, Keith Wheatley, Benjamin Djulbegovic, MD, PhD

Blood (2012) 120 (21): 236.

https://doi.org/10.1182/blood.V120.21.236.236

Published: 2012

Journal Articles

Forest Plot to Compare Therapies in a Network Meta-Analysis in First Line Chronic Lymphocytic Leukemia

Alfonso Piciocchi, Katia Bontempi, Paola Fazi, Marco Vignetti, Franco Mandelli, MD

Blood (2012) 120 (21): 4596.

https://doi.org/10.1182/blood.V120.21.4596.4596

Published: 2012

NARROW

Evaluation of Efficacy and Safety of Front-Line Regimens for the Treatment of Transplant Ineligible Patients with Multiple Myeloma: A Network Meta-Analysis of Phase 2/3 Randomized Controlled Trials

A Network Meta-Analysis (NMA) to Evaluate Comparative Effectiveness of Frontline Treatments for Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Who Are Transplant-Ineligible (TIE)

A Network Meta-Analysis of Clinical Trials Assessing Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Among Young Adults

Aspirin Use in Venous Thromboembolism Prophylaxis Following Hip or Knee Arthroplasty: A Network Meta-Analysis of Randomized Controlled Trials

Treatment Regimens for Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Stem Cell Transplantation: A Systematic Literature Review and Network Meta-Analysis

Relative Efficacy of Treatment Options in Newly Diagnosed Multiple Myeloma: Results from a Systematic Literature Review and Network Meta-Analysis

Estimating the Effect of Individual Agents in the Treatment of Relapsed, Refractory Multiple Myeloma (RRMM)

Comparison of Different Rabbit Anti-Thymocyte Globulin Formulations in Allogeneic Stem Cell Transplantation: Systematic Literature Review and Network Meta-Analysis

Direct Oral Anticoagulants for the Prevention of Recurrent Venous Thromboembolism: A Systematic Review & Network Meta-Analysis

A Systematic Review and Network Meta-Analysis of Maintenance Treatment for Patients with Newly Diagnosed Multiple Myeloma Post-Autologous Stem Cell Transplant

Risk of Intracranial Hemorrhage with Direct Oral Anticoagulants: A Traditional and Network Meta-Analysis

Systematic Literature Review and Network Meta-Analysis of Treatments for Relapsed/Refractory Multiple Myeloma Patients

Impact of Dose-Difference in Comparator Arms Among Clinical Trials on Treatment Effect Size in a Network Meta-Analysis: A Case of First-Line Therapies in Chronic Lymphocytic Leukemia (CLL)

Efficacy of First-Line CLL Treatments in Comparison to Chlorambucil: A Network Meta-Analysis

Estimating the Relative Effectiveness of Treatments in Relapsed/Refractory Multiple Myeloma through a Systematic Review and Network Meta-Analysis

Comparative Analysis of Azacitidine and Decitabine in Myelodysplastic Syndromes: A Systematic Review and Network Meta-Analysis

Bayesian Network Meta-Analysis (NMA): Safety of Bortezomib, Thalidomide or Lenalidomide Containing Regimens for Transplant Ineligible Multiple Myeloma (MM) Patients

Efficacy Of Novel Agents As Maintenance Therapy For Multiple Myeloma: A Direct and Network Meta-Analysis

Maintenance Therapies for Multiple Myeloma (MM): A Network Meta-Analysis

Forest Plot to Compare Therapies in a Network Meta-Analysis in First Line Chronic Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only